$TNXP News Article - Tonix Pharmaceuticals Enrolls First Patient in COV-LOGIC, an Observational Study to Assess Antibody and T Cell Responses to SARS-CoV-2, the Virus that Causes COVID-19 https://marketwirenews.com/news-releases/toni...54693.html
(0)
(0)
Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Research Links